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Introduction
Liver transplant recipients (LTR) may require percuta-
neous dilational tracheotomy (PDT) during the immediate
postoperative period or later because of need for pro-
longed mechanical ventilation or airway issues. However,
despite the increased risk of bleeding and infections, there
is little data regarding the safety and effectiveness of PDT
in LTRs.
Objectives
The aim of this study was to evaluate the safety and
effectiveness, in terms of changes in oxygenation and
lung compliance, of PDT in LTRs.
Methods
We reviewed the data of liver transplant recipients who
underwent percutaneous dilational tracheotomy in Baskent
University Hospital between January 2010 and March 2015.
Collected data included demographics (age, sex, body
weight, length); etiology of chronic liver failure; comorbid-
ities; Child, Model for End Stage Liver Disease (MELD),
acute physiology and chronic health evaluation II
(APACHE II), and sequential organ failure assessment
(SOFA) scores; length of hospitalization and mechanical
ventilation; etiology of acute respiratory failure;
pre-PDTPlatelet count and international normalized ratio
(INR) values; partial pressure of arterial oxygen to fractional
inspired oxygen ratio (P/F), and pulmonary compliance.
Pre- and post-PDT values were compared using
Wilcoxon test.
Results
Out of 136 LTRs 16 required PDT during the study period.
All PDTs were performed by experienced intensivists and
under bronchoscopic guidance using Percutwist or Ciaglia
techniques. The mean age was 35.4 ± 16.5 years and mean
body mass index was 25.5 ± 6.0 kg/m2. The mean Child
and MELD scores were 10.5 ± 1.9 and 23.5 ± 7.7, respec-
tively. The mean APACHE II on admission was 25.4 ± 11.9
Pre-PDT platelet count and INR were 47000 ± 41000 per
µl and 2.0 ± 0.8, respectively. The indication for PDT was
prolonged mechanical ventilation for all patients. The
etiology of acute respiratory failure was most commonly
extrapulmonary (%87.5). The mean interval from trans-
plantation to PDT was 355 ± 870 days. The only major
complication noted was left-sided pneumothorax in one
patient. Six patients had minor, sel-limiting bleeding from
the tracheotomy site on the first day of post-PDT. There
were no significant differences between pre-PDT and post-
PDT P/F ratios (261 ± 203 vs 264 ± 132; p:0.534). However
pre- and post-PDT pulmonary compliances were signifi-
cantly different (0.02 ± 0.02 L/cmH2O vs 0.03 ± 0.02
L/cmH2O, p:0.002). The number of patients who required
sedation significantly decreased after PDT (7 versus 1,
p = 0.03).
Conclusions
When performed by experienced intensivists using
bronchoscopic guidance PDT is safe in LTR. PDT may
also improve lung mechanics and decrease the need of
sedation in these patients.
Published: 1 October 2015
doi:10.1186/2197-425X-3-S1-A905
Cite this article as: Kundakci Ozdemirkan et al.: Percutaneous dilational
tracheotomy in liver transplant recipients. Intensive Care Medicine
Experimental 2015 3(Suppl 1):A905.
Baskent University, Ankara, Turkey
Kundakci Ozdemirkan et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A905
http://www.icm-experimental.com/content/3/S1/A905
© 2015 Kundakci Ozdemirkan et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.
